E. Kneepkens - Concepedia

Author

E. Kneepkens

Reade

Also Known As

E L Kneepkens, E. Kneepkens, E.L. Kneepkens, Eva L Kneepkens, Eva L. Kneepkens, Eva Linda Kneepkens

Publications

665

Citations

H-Index

Concepts

All Affiliations

Reade Sanquin Amsterdam UMC Location Vrije Universiteit Amsterdam Radboud University Nijmegen Radboud University Medical Center

About

E. Kneepkens is an author at Reade.

E. Kneepkens

Publications

565

Citations

H-Index

Page 1

	Year	Citations
Immunogenicity, adalimumab levels and clinical response in ankylosing spondylitis patients during 24 weeks of follow-up E. Kneepkens, James Cheng‐Chung Wei, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2013	88
Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up Erik H Vogelzang, E. Kneepkens, Michael T. Nurmohamed, Annals of the Rheumatic Diseases	2014	79
Medication-Related Hospital Readmissions Within 30 Days of Discharge: Prevalence, Preventability, Type of Medication Errors and Risk Factors Elien B. Uitvlugt, Marjo J. A. Janssen, C. E. H. Siegert, Frontiers in Pharmacology	2021	71
Lower etanercept levels are associated with high disease activity in ankylosing spondylitis patients at 24 weeks of follow-up E. Kneepkens, C. Krieckaert, Desirée van der Kleij, Annals of the Rheumatic Diseases	2014	61
Capillary Blood Microsampling to Determine Serum Biopharmaceutical Concentration: Mitra <sup>®</sup> Microsampler vs Dried Blood Spot Karien Bloem, Tiny Schaap, Ronald S. Boshuizen, Bioanalysis	2018	52
Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti‐adalimumab in patients with inflammatory diseases E. Kneepkens, Mieke F. Pouw, Tiny Schaap, British Journal of Clinical Pharmacology	2017	43
Comparing Tapering Strategy to Standard Dosing Regimen of Tumor Necrosis Factor Inhibitors in Patients with Spondyloarthritis in Low Disease Activity Chamaida Plasencia, E. Kneepkens, Gertjan Wolbink, The Journal of Rheumatology	2015	36
Unexpected arterial wall and cellular inflammation in patients with rheumatoid arthritis in remission using biological therapy: a cross-sectional study Sophie J. Bernelot Moens, Fleur M. van der Valk, Aart C. Strang, Arthritis Research & Therapy	2016	33
Preventability of unplanned readmissions within 30 days of discharge. A cross-sectional, single-center study Albertine M. B. van der Does, E. Kneepkens, Elien B. Uitvlugt, PLoS ONE	2020	27
The Effects of 5-year Etanercept Therapy on Cardiovascular Risk Factors in Patients with Psoriatic Arthritis Rabia Agca, Maaike Heslinga, E. Kneepkens, The Journal of Rheumatology	2017	20

Page 1